NCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
Clinical Trials
12 trialsNCT07258043 2025-12-02
EPOCH
Hospital General de Mexico
Recruiting
NCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT06026046 2025-09-19
EscrimHEMA
University Hospital, Angers
Phase NA Active not recruiting
NCT07120607 2025-08-13
Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT06795815 2025-06-12
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT05477589 2024-12-19
SCRIPT-AML
Vastra Gotaland Region
Phase 3 Recruiting
NCT06262789 2024-02-16
RAT-HEMATO
University Hospital, Angers
Phase NA Not yet recruiting
NCT05528887 2022-09-06
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase 1 Recruiting
NCT04745416 2021-02-09
Clinical Characteristics of Patients With Leukemia and COVID-19
Hospital General de Mexico
Completed
NCT01642563 2015-07-28
IPTAS
Centro Nazionale Sangue
Phase 3 Terminated
NCT00566566 2007-12-03
Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors
Sheba Medical Center
Unknown